FOXO Technologies Inc (FOXO) USD0.0001 A
Sell:$0.15Buy:$0.16
$0.01
(4.43%)
- This stock can be held in a
Stocks and Shares ISA$0.01
(4.43%)$0.01
(4.43%)Company Information
About this company
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Key people
Key facts
- EPICFOXO
- LocationUnited States
- SectorTechnology
- IndustryComputer Services
- ISINUS3514713052
- Market cap$3.68m
- Employees24
- Shares in issue23.57m
- ExchangeNyse American LLC
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.